Sponsor content
175 result(s) found, displaying 61 to 70
-
Australian public assessment report (AusPar)AusPAR for Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy for advanced disease.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Amgen Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.
-
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: carfilzomib.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REPATHA evolocumab (rch) 420 mg/3.5 mL injection solution automated mini-doser AMD.
-
Cancellation by sponsorRequested by Amgen Australia Pty Ltd